Form 10-Q - Quarterly report [Sections 13 or 15(d)]

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Contango Ore (AMEX:CTGO)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Contango Ore Charts.

Contango Ore (AMEX:CTGO)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Contango Ore Charts.

Contango Ore Inc News

Form 8-K - Current report
Thursday 19 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Contango Announces $9.0 Million Cash Distribution from the Peak Gold JV
Thursday 19 December 2024 (3 weeks ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 12 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 29 November 2024 (1 month ago) • Edgar (US Regulatory)

Contango Reaffirms and Updates 2025 Manh Choh Guidance
Friday 29 November 2024 (1 month ago) • PR Newswire (US)

Form EFFECT - Notice of Effectiveness
Thursday 28 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

Contango Ore Provides Update and 2024 Drill Results for the Johnson Tract Project, Alaska, USA
Thursday 21 November 2024 (2 months ago) • PR Newswire (US)

Form S-3 - Registration statement under Securities Act of 1933
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

More Contango Ore Inc News Articles

Northwest Biotherapeutics (QB)

Elite Pharmaceuticals (QB)

Rennova Health (CE)

Fannie Mae (QB)

Tonix Pharmaceuticals

Bioelectronics (PK)

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions